Optically active 2-amino-1-arylethanols are important structural elements in chiral drugs such as α-or β-adrenergic blockers and agonists in the treatment of cardiovascular disease, cardiac failure, asthma and glaucoma.
1 Examples for such chiral drugs include (R)-phenylephrine (1), (R)-norfenifefrine (2), (R)-synephrine (3), (R)-octopamine (4) and (R)-pronethalol (5), (R)-tembamide (6) and (R)-aegeline (7) (Figure 1 ). For the synthesis of chiral 2-amino-1-arylethanols, catalytic hydrogenation of optically active 2-azido-1-arylethanols obtained from enzymatic resolution of racemic mixture, 2 enantio-or regioselective azidolysis of chiral aryloxiranes, 3a-f azidation of chiral 1,2-diol monotosylates and asymmetric reduction of 2-azido-1-arylethanones 4a,b,5,6 have been reported. However, the resolution methods suffer from the fact that the theoretical yields are limited to 50%. 2b Azidolysis of aryloxiranes are commonly accompanied by the formation of undesired regioisomers with the azido group at the benzylic position.
3b-f For other synthetic methods of non-racemic β-amino alcohols, reduction of chiral arylcyanonohydrins 7 and aminolysis of chiral 1,2-diol monotosylates have been published. 8 One of the most convenient synthesis is the direct asymmetric reduction of Nprotected β-amino ketones. For this, there are only two reports including bakers yeast reduction 9 and asymmetric transfer hydrogenation 10 of α-(acyl or alkoxycarbonylamino)-acetophenones. Since Itsuno 11 and Corey 12 reported the first oxazaborolidine-catalyzed asymmetric borane reduction, a number of such reductions of prochiral ketones has been extensively studied. However there are no reports for the asymmetric reduction of α-amino ketone derivatives using these catalytic reducing agents. Recently we reported very effective CBS-oxazaborolidine-catalyzed asymmetric borane reduction of various α-functionalized ketones to give the corresponding alcohols with high enantioselcetivies. 13 On the other hand, it has been known that (−)-B-chlorodiisopinocampheylborane ( d Ipc 2 BCl) is a commercially available and highly effective asymmetric reducing agent for the asymmetric reduction of various prochiral ketones to provide high enantioselectivity with predictable stereochemistry.
14 In connection with our continuing efforts toward asymmetric reduction of functionalized ketones, we investigated the asymmetric reduction of 2-N-Boc (or Cbz)-amino-1-arylethanones using those chiral reducing agents.
First, we carried out (S)-CBS-oxazaborolidine (10)-catalyzed asymmetric borane reduction of 2-N-Boc-amino-1-phenylethanone 8a using environmentally benign borane carrier, N-ethyl-N-isopropylaniline-borane complex 11, as the hydride source in THF at 25 o C (Method A). As shown in Table 1 , slow addition of 8a over 1 h to a solution of 0.6 equiv of borane-THF in the presence of 10 mol% of (S)-10 in THF at 25 o C afforded 2-N-Boc-amino-1-phenylethanol (9a) within 10 min in 93% yield. HPLC analysis of 9a using a Chiralcel OD-H column (eluent : hexane/i-PrOH/Et 2 NH = 95 : 5 : 0.1) showed it to be 98% ee (entry 1). The reduction of 8b, protected with Cbz group instead of Boc group of 8a, provided a similar result under the identical condition (entry 2). Also, we investigated the reduction of 8a and 8b with d Ipc2BCl (12). Unfortunately, the reduction using 1.2 equiv of 12 in THF at -25 o C (Method C) afforded 9a and 9b in low yields with moderate enantioselectivity (entries 3-4). On the other hand, (9e) and (R)-2-N-Boc-amino-1-(2-naphthyl)ethanol (9h) can be effectively used as key intermediates for the synthesis of chiral drugs 1-7. Therefore we applied the CBSoxazaborolidine-catalyzed reduction to the synthesis of these intermediates. Thus, the reduction of 8c-e using (R)-10 as the catalyst (Method B) under the same conditions as those adopted in Method A provided 9c-h with high enantioselectivities in high yields (entries 5-7 and 10) . Similarly, the CBS-oxazaborolidine reduction of other N-Boc amino ketones including a heterocyclic analogue provided good enantioselectivities (entry 8-9 and 11). In summary, we have established an efficient synthesis of optically active 2-N- Boc-amino-1-arylethanols which can be used as key intermediates for the synthesis of various chiral β-adrenergic drugs by oxazaborolidine-catalyzed reduction using (R)-10 as catalyst.
Experimental Section
General. The reactions were monitored by TLC using silica gel plates and the products were purified by flash column chromatography on silica gel (Merck; 230-400 mesh). NMR spectra were recorded at 300 MHz for 1 H and 75 MHz for 13 C using Me4Si as the internal standard in CDCl3 unless otherwise noted. Optical rotations were measured with a high resolution digital polarimeter. Melting points were uncorrected. Most of organic compounds utilized in this study were commercial products of the highest purity. They were further purified by distillation when necessary. THF was distilled over sodium benzophenone ketyl and stored in ampules under nitrogen atmosphere. (R)-and (S)-CBS-oxazaborolidine reagent 10, N-ethyl-N-isopropylaniline-borane complex 11 and (−)-B-chlorodiisopinocampheylborane 12 were purchased from the Aldrich Chemical Company. Enantiomeric excesses (ees) of the products were determined with a HPLC apparatus fitted with a 25 cm Chiralcel OD-H (Daicel) chiral column using hexane/ ethanol/diethylamine 95 : 5 : 0.1 as eluent unless otherwise indicated.
Asymmetric Reduction of 2-N-Boc (or Cbz)-amino-1-arylethanones 1.
General Procedure: Method A and B: The reduction was carried out in THF at 25 o C using (R)-or (S)-10 and 11 as catalyst and borane carrier, respectively, according to the known procedure. 13 Method C: The reduction was carried out by the literature procedure. 15 The reduction product β-amino alcohol derivatives obtained were further purified by a flash column chromatography on silica gel (230-400 mesh) using EtOAc/hexane 1 : 2 as eluent.
(S)-2-N-Boc-amino- 72, 48.70, 74.26, 80.12, 126.05, 127.97, 128.66, 141.97; Calcd. for C13H19NO3: C, 65.80; H, 8.07; N, 5.90. Found: C, 65.65; H, 8.06; N, 6.09;  +54.18 (c 0.6, CHCl3), +3.7 (c 1.0, EtOH) {lit. 74, 48.68, 70.24, 74.22, 80.21, 112.44, 114.41, 118.65, 127.73, 128.19, 128.78, 129.78, 137.04, 143.72, 159.10; Calcd. for C 20 H 25 NO 4 : C, 69.95; H, 7.34; N, 4.08. Found: C, 69.89; H, 7.41; N, 4.05; CHCl 3 ). This value is correspondent to be 88% ee by comparison with optical rotation value of authentic 9c in 100% ee { -34.8 (c 0.3, CHCl 3 )} obtained from catalytic hydrogenation of the corresponding azido alcohol proven to be 100% ee by HPLC analysis using a Chiralcel OD-H chiral column. 74, 48.67, 70.34, 73.80, 80.05, 115.08, 107.32, 127.62, 128.14, 128.76, 134.44, 137.12, 158.60; Calcd. for C 20 H 25 NO 4 : C, 69.95; H, 7.34; N, 4.08. Found: C, 69.86; H, 7.45; N, 4.06; CHCl 3 ); HPLC analysis showed it to be 93% ee, R [flow rate = 0. ) 3403, 3371, 2977, 2932, 1671, 1512, 1252, 1169; 1 H NMR (300 MHz, CDCl 3 ) δ 1.44 (s, 9H), 3.11 (brs, 1H), 3.19-3.26 (m, 1H), 3.38-3.45 (m, 1H), 3.79 (s, 3H), 4.74-4.76 (m, 1H), 4.98 (brs, 1H), 6.85-6.88 (m, 2H), 7.24-7.27 (m, 2H) ; 13 C NMR (75 MHz, CDCl 3 ) δ 28. 73, 48.69, 55.60, 73.85, 80.05, 114.13, 127.28, 134.12, 159.42; Calcd. for C 14 H 21 NO 4 : C, 62.90; H, 7.92; N, 5.24. Found: C, 62.93; H, 8.01; N, 5.31; CHCl 3 ); HPLC analysis showed it to be 81% ee, R [flow rate = 0.5 mL/min; tR(R) 11.07 min and tR(S) 13. 77, 29.01, 49.01, 74.39, 80.44, 126.52, 129.86, 138.18, 139.55, 157.57; Calcd. for C14H21NO3: C, 66.91; H, 8.42; N, 5.57. Found: C, 66.92; H, 8.46; N, 5.58; +43.8 (c 1.0, CHCl3) ; HPLC analysis showed it to be 87% ee, S [flow rate = 0.5 mL/min; tR(R) 14.22 68, 48.72, 73.70, 79.96, 127.45, 128.77, 128.83, 133.62, 140.51; Calcd. for C 13 H 18 ClNO 4 : C, 57.46; H, 6.68; N, 5.15. Found: C, 57.44; H, 6.59; N, 5.13; +46.3 (c 0.5, CHCl 3 ); HPLC analysis showed it to be 89% ee, S [flow rate = 0.5 mL/min; t R (R) 7.82 min and t R (S) 9.97 min].
(R)-2-N-Boc-amino- 74, 48.66, 74.41, 80.27, 124.10, 124.95, 126.15, 126.43, 127.89, 128.17, 128.47, 133.17, 133.38, 139.37, 157.29; Calcd. for C 17 H 21 NO 3 : C, 71.06; H, 7.37; N, 4.87. Found: C, 71.07; H, 7.32; N, 4.67; .2 (c 0.7, CHCl 3 ); HPLC analysis showed it to be 87% ee, R [flow rate = 0.5 mL/min; t R (R) 13.66 min and t R (S) 15 69, 48.76, 73.74, 80.36, 127.43, 128.79, 133.64, 140.48; Calcd. for C 11 H 17 NO 3 S: C, 54.30; H, 7.04; N, 5.76; S, 13.18. Found: C, 54.30; H, 7.22; N, 5.65; S, 13.15;  +37.3 (c 0.9, CHCl 3 ); HPLC analysis showed it to be 82% ee, R [flow rate = 0.5 mL/min; t R (S) 9.97 min and t R (R) 11.00 min]. 
